Journal of the Neurological Sciences
Volume 290, Issue 1 , Pages 16-21 , 15 March 2010

Methylation patterns of cell-free plasma DNA in relapsing–remitting multiple sclerosis

  • Thomas Liggett

      Affiliations

    • Rush University Medical Center, Department of Neurological Sciences, Multiple Sclerosis Center, 1745 W. Harrison Street, Ste 309, Chicago, IL 60612, USA
    • These authors contributed equally to the experimental design and the microarray work.
    • ,
  • Anatoliy Melnikov

      Affiliations

    • Rush University Medical Center, Department of Radiation Oncology, 1750 W. Harrison Street, Jelke Bldg, 1303, Chicago, IL 60612, USA
    • These authors contributed equally to the experimental design and the microarray work.
    • ,
  • Shilpa Tilwalli

      Affiliations

    • Rush University Medical Center, Department of Neurological Sciences, Multiple Sclerosis Center, 1745 W. Harrison Street, Ste 309, Chicago, IL 60612, USA
    • ,
  • Qilong Yi

      Affiliations

    • ScienceDocs Inc., 10940 SW Barnes Road, Ste. 270, Portland, OR 97225, USA
    • ,
  • Haiyan Chen

      Affiliations

    • ScienceDocs Inc., 10940 SW Barnes Road, Ste. 270, Portland, OR 97225, USA
    • ,
  • Charles Replogle

      Affiliations

    • ScienceDocs Inc., 10940 SW Barnes Road, Ste. 270, Portland, OR 97225, USA
    • ,
  • Xuan Feng

      Affiliations

    • University of Chicago, Department of Neurology, 5841 S. Maryland Street, MC-2030, Chicago, IL 60637, USA
    • ,
  • Anthony Reder

      Affiliations

    • University of Chicago, Department of Neurology, 5841 S. Maryland Street, MC-2030, Chicago, IL 60637, USA
    • ,
  • Dusan Stefoski

      Affiliations

    • Rush University Medical Center, Department of Neurological Sciences, Multiple Sclerosis Center, 1745 W. Harrison Street, Ste 309, Chicago, IL 60612, USA
    • ,
  • Roumen Balabanov

      Affiliations

    • Rush University Medical Center, Department of Neurological Sciences, Multiple Sclerosis Center, 1745 W. Harrison Street, Ste 309, Chicago, IL 60612, USA
    • Corresponding Author InformationCorresponding authors. Levenson is to be contacted at Rush University Medical Center, Department of Radiation Oncology, 1750 W. Harrison Street, Jelke Bldg, 1303, Chicago, IL 60612, United States. Tel.: +1 312 942 0555. Balabanov, Rush University Medical Center, Department of Neurological Sciences, Multiple Sclerosis Center, 1745 W. Harrison Street, Chicago, IL 60612, United States. Tel.: +1 312 942 8011.
    • ,
  • Victor Levenson

      Affiliations

    • Rush University Medical Center, Department of Radiation Oncology, 1750 W. Harrison Street, Jelke Bldg, 1303, Chicago, IL 60612, USA
    • Corresponding Author InformationCorresponding authors. Levenson is to be contacted at Rush University Medical Center, Department of Radiation Oncology, 1750 W. Harrison Street, Jelke Bldg, 1303, Chicago, IL 60612, United States. Tel.: +1 312 942 0555. Balabanov, Rush University Medical Center, Department of Neurological Sciences, Multiple Sclerosis Center, 1745 W. Harrison Street, Chicago, IL 60612, United States. Tel.: +1 312 942 8011.

Received 13 October 2009 ,Revised 15 December 2009 ,Accepted 17 December 2009.

References 

  1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372(9648):1502–1517
  2. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria”. Ann Neurol. 2005;58(6):840–846
  3. Bielekova B, Martin R. Development of biomarkers in multiple sclerosis. Brain. 2004;127(Pt 7):1463–1478
  4. Berger T, Rubner P, Schautzer F, Egg R, Ulmer H, Mayringer I, et al. Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event. N Engl J Med. 2003;349(2):139–145
  5. Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, Rothlein R, et al. Circulating, soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol. 1995;37(1):55–62
  6. Freedman MS, Thompson EJ, Deisenhammer F, Giovannoni G, Grimsley G, Keir G, et al. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch Neurol. 2005;62(6):865–870
  7. Rejdak K, Petzold A, Stelmasiak Z, Giovannoni G. Cerebrospinal fluid brain specific proteins in relation to nitric oxide metabolites during relapse of multiple sclerosis. Mult Scler. 2008;14(1):59–66
  8. Whitaker JN. Myelin basic protein in cerebrospinal fluid and other body fluids. Mult Scler. 1998;4(1):16–21
  9. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, Briggs F, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006;15(18):2813–2824
  10. Gregory SG, Schmidt S, Seth P, Oksenberg JR, Hart J, Prokop A, et al. Interleukin 7 receptor alpha chain (IL7R) shows allelic and functional association with multiple sclerosis. Nat Genet. 2007;39(9):1083–1091
  11. Hafler DA, Compston A, Sawcer S, Lander ES, Daly MJ, De Jager PL, et al. Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. 2007;357(9):851–862
  12. Oksenberg JR, Baranzini SE, Sawcer S, Hauser SL. The genetics of multiple sclerosis: SNPs to pathways to pathogenesis. Nat Rev Genet. 2008;9(7):516–526
  13. Baylin SB. DNA methylation and gene silencing in cancer. Nat Clin Pract Oncol. 2005;2(Suppl 1):S4–S11
  14. Delgado J. Novel epigenetic targets in lymphoproliferative disorders. Curr Cancer Drug Targets. 2008;8(5):378–391
  15. Sanchez-Pernaute O, Ospelt C, Neidhart M, Gay S. Epigenetic clues to rheumatoid arthritis. J Autoimmun. 2008;30(1–2):12–20
  16. Strickland FM, Richardson BC. Epigenetics in human autoimmunity. Epigenetics in autoimmunity — DNA methylation in systemic lupus erythematosus and beyond. Autoimmunity. 2008;41(4):278–286
  17. Casaccia-Bonnefil P, Pandozy G, Mastronardi F. Evaluating epigenetic landmarks in the brain of multiple sclerosis patients: a contribution to the current debate on disease pathogenesis. Prog Neurobiol. 2008;86(4):368–378
  18. Chao MJ, Ramagopalan SV, Herrera BM, Lincoln MR, Dyment DA, Sadovnick AD, et al. Epigenetics in multiple sclerosis susceptibility: difference in transgenerational risk localizes to the major histocompatibility complex. Hum Mol Genet. 2009;18(2):261–266
  19. Bearzatto A, Conte D, Frattini M, Zaffaroni N, Andriani F, Balestra D, et al. p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer. Clin Cancer Res. 2002;8(12):3782–3787
  20. Anker P, Stroun M, Maurice PA. Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system. Cancer Res. 1975;35(9):2375–2382
  21. Leon SA, Shapiro B, Sklaroff DM, Yaros MJ. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37(3):646–650
  22. Lo YM, Rainer TH, Chan LY, Hjelm NM, Cocks RA. Plasma DNA as a prognostic marker in trauma patients. Clin Chem. 2000;46(3):319–323
  23. Rainer TH, Wong LK, Lam W, Yuen E, Lam NY, Metreweli C, et al. Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke. Clin Chem. 2003;49(4):562–569
  24. Melnikov A, Scholtens D, Godwin A, Levenson V. Differential methylation profile of ovarian cancer in tissues and plasma. J Mol Diagn. 2009;11(1):60–65
  25. Melnikov AA, Scholtens D, Talamonti MS, Bentrem DJ, Levenson VV. Methylation profile of circulating plasma DNA in patients with pancreatic cancer. J Surg Oncol. 2009;99(2):119–122
  26. Giacona MB, Ruben GC, Iczkowski KA, Roos TB, Porter DM, Sorenson GD. Cell-free DNA in human blood plasma: length measurements in patients with pancreatic cancer and healthy controls. Pancreas. 1998;17(1):89–97
  27. Christensen BC, Houseman EA, Marsit CJ, Zheng S, Wrensch MR, Wiemels JL, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009;5(8):e1000602
  28. Gelman AE, Zhang J, Choi Y, Turka LA. Toll-like receptor ligands directly promote activated CD4+ T cell survival. J Immunol. 2004;172(10):6065–6073
  29. Kabelitz D. Expression and function of Toll-like receptors in T lymphocytes. Curr Opin Immunol. 2007;19(1):39–45
  30. Vollmer J, Tluk S, Schmitz C, Hamm S, Jurk M, Forsbach A, et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J Exp Med. 2005;202(11):1575–1585
  31. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, Marshak-Rothstein A. Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature. 2002;416(6881):603–607
  32. Pietschmann K, Beetz S, Welte S, Martens I, Gruen J, Oberg HH, et al. Toll-like receptor expression and function in subsets of human gammadelta T lymphocytes. Scand J Immunol. 2009;70(3):245–255
  33. Brentano F, Schorr O, Gay RE, Gay S, Kyburz D. RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum. 2005;52(9):2656–2665
  34. Holm CK, Petersen CC, Hvid M, Petersen L, Paludan SR, Deleuran B, et al. TLR3 ligand polyinosinic:polycytidylic acid induces IL-17A and IL-21 synthesis in human Th cells. J Immunol. 2009;183(7):4422–4431
  35. Komatsuda A, Wakui H, Iwamoto K, Ozawa M, Togashi M, Masai R, et al. Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol. 2008;152(3):482–487
  36. Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, et al. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupus erythematosus. Rheumatology (Oxford). 2008;47(2):145–149
  37. Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K, et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest. 2006;116(2):456–464
  38. Duramad O, Fearon KL, Chang B, Chan JH, Gregorio J, Coffman RL, et al. Inhibitors of TLR-9 act on multiple cell subsets in mouse and man in vitro and prevent death in vivo from systemic inflammation. J Immunol. 2005;174(9):5193–5200
  39. Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann N Y Acad Sci. 2008;1143:21–34
  40. Hansen BS, Hussain RZ, Lovett-Racke AE, Thomas JA, Racke MK. Multiple toll-like receptor agonists act as potent adjuvants in the induction of autoimmunity. J Neuroimmunol. 2006;172(1–2):94–103
  41. Krieg AM, Vollmer J. Toll-like receptors 7, 8, and 9: linking innate immunity to autoimmunity. Immunol Rev. 2007;220:251–269
  42. Melnikov AA, Scholtens DM, Wiley EL, Khan SA, Levenson VV. Array-based multiplex analysis of DNA methylation in breast cancer tissues. J Mol Diagn. 2008;10(1):93–101
  43. Liggett T, Melnikov A, Yi Q, Replogle C, Brand R, Kaul K, Talamonti M, Abrams R, Levenson V. Differential methylation of cell-free circulating DNA in patients with pancreatic cancer and chronic pancreatitis. Cancer. in press.

PII: S0022-510X(09)01021-1

doi: 10.1016/j.jns.2009.12.018

Journal of the Neurological Sciences
Volume 290, Issue 1 , Pages 16-21 , 15 March 2010

Article Tools

* Image Usage & Resolution